Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 14,334 | 13,659 | 13,169 | 10,280 | 11,550 |
| Operating Income | -14,334 | -13,659 | -13,169 | -10,280 | -11,550 |
| Other Income | 15 | 12 | 8 | 23 | 32 |
| Pre-tax Income | -14,319 | -13,647 | -13,161 | -10,257 | -11,518 |
| Net Income Continuous | -14,319 | -13,647 | -13,161 | -10,257 | -11,518 |
| Net Income | $-14,319 | $-13,647 | $-13,161 | $-10,257 | $-11,518 |
| EPS Basic Total Ops | -2.00 | -2.20 | -2.96 | -2.32 | 8.36 |
| EPS Basic Continuous Ops | -1.99 | -2.19 | -2.97 | -2.33 | 1.62 |
| EPS Diluted Total Ops | -2.00 | -2.20 | -2.96 | -2.32 | 8.36 |
| EPS Diluted Continuous Ops | -1.99 | -2.19 | -2.97 | -2.33 | 1.62 |
| EBITDA(a) | $-14,257 | $-13,618 | $-13,113 | $-10,200 | $-11,348 |